Allyx Therapeutics, Inc.
through Oct 21, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | May 11, 2026 · D | Oct 21, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $29,999,999 | $29,999,999 | $0 |
| Reported amount sold | $26,427,730 | $27,927,729 | $1,499,999 |
| Reported investor count | — | 33 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001865257-26-000004 · Later SEC source: 0001865257-26-000005
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $29,999,999
- Reported amount sold
- $27,927,729
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (3)
-
0001865257-26-000005D/A · Oct 21, 2026 · BiotechnologyOffering: $29,999,999Sold: $27,927,729
-
0001865257-26-000004D · May 11, 2026 · BiotechnologyOffering: $29,999,999Sold: $26,427,730
-
0001865257-26-000003D · Mar 3, 2026 · BiotechnologyOffering: $4,000,000Sold: $3,324,918